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Background: Up-regulation of UHRF1 has been observed in a variety of cancers and appears to serve as an
independent prognostic factor.
Objective: To explore the effect of UHRF1 gene silencing on apoptosis and proliferation of cervical squamous cell
carcinoma (CSCC) CaSki cells.
Methods: This study consisted of 47 CSCC tissues and 40 normal cervical tissues. The CaSki cells were assigned into
Blank group (CaSki cells not transfected), NC group (CaSki cells transfected with control siRNA), and UHRF1 Silence
group (CaSki cells transfected with UHRF1 siRNA). qRT-PCR and Western blot were used for UHRF1 mRNA and
protein expressions, CKK-8 assay for cell proliferation, flow cytometry for cell cycle and apoptosis, Western blot
for expressions of apoptosis-related proteins. Nude mice tumor transplant experiment was performed.
Results: UHRF1 exhibited higher mRNA and protein expressions in the CSCC tissues than normal cervical
tissues (both P < 0.05). The cell proliferation ability in the UHRF1 Silence group was reduced when compared
with the Blank group and the NC group, the cells at S-G2M stage in the UHRF1 Silence group were dropped
when compared with the Blank group and the NC group (P < 0.05), while the cells at G0/G1 stage were elevated
(P < 0.05), and the proportion of Annexin V positive cells in the UHRF1 Silence group was increased in comparison with
the Blank group and the NC group (P < 0.05). Nude mice tumor transplant experiment indicated that the growth rate
and weight of tumor in the Blank group and NC group was higher and heavier than the UHRF1 Silence group (P < 0.05).
Conclusion: UHRF1 showed a high expression in CSCC and UHRF1 silencing can reduce proliferation and enhance
apoptosis of the CaSki cells.
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Cervical cancer is the third most commonly diagnosed
gynecologic cancer and the fourth major cause of death-
related cancer in females worldwide, accounting for 9 %
of the total new diagnoses and 8 % of the total cancer-
associated deaths among females in 2008 [1]. In China,
there were 87,982 new patients diagnosed as cervical
cancer and 23,375 deaths in 2011, and this disease has
become one of the heaviest health burdens among
Chinese women [2]. The major cause of cervical cancer* Correspondence: hilouge@126.com
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fection, which is detected in 99 % of patients with
cervical tumors [3]. Interestingly, cervical cancer de-
velops in a multi-step process that implicates the
transformation of normal cervical epithelium into pre-
neoplastic cervical intraepithelial neoplasia (CIN) that ul-
timately progress to invasive cervical cancer cells [4].
Accounting for 70 ~ 80 % of cervical cancers, cervical
squamous cell carcinoma (CSCC) consists of cells which
are recognizably squamous but different from each other
in term of growth pattern or cytological morphology [3].
The latest study reported there is no apparent symptom
of early cervical cancer, while locally advanced disease
may result in abnormal vaginal bleeding, pelvic pain,le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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Table 1 PCR primer sequences
Gene Primer sequence
UHRF1 Forward: 5’- ACCAAGGTGGAGCCCTACAG -3’
Reverse: 5’- CACTTTACTCAGGAACAACTGGAAC -3’
β-actin Forward: 5’-CATCACGTACCAAACTTCAA-3’
Reverse: 5’-CATCACAGTACCGGATTGC-3’
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ing of the gene or molecular mechanisms via which
pre-invasive lesions have the capability of invading
the cervical stroma and eventually metastasis would
exert significantly clinical influence.
UHRF1 [ubiquitin-like, containing plant homeodo-
main (PHD) and really interesting new gene (RING)
finger domains 1], also known as ICBP90 or Np95, is
a member of UHRF family and encode a 95-kDa nu-
clear protein of 793 amino acids, with a single open
reading frame (ORF) [5]. It contains an N-terminal
ubiquitylation-like domain, PHD, a SRA (SET and
RING-associated) domain and a RING finger motif
domain [6]. During the recent years, UHRF1 has re-
ceived great concerns as a novel diagnostic marker of
cancer [7]. UHRF1 is featured by a SRA domain (Set
and Ring Associated) only found in the UHRF family,
and up-regulation of UHRF1 has been observed in a
variety of cancers, such as lung cancer and bladder
cancer [8, 9]. Also, previous studies demonstrated
that the expression level of UHRF1 is closely associ-
ated with clinical stage, metastatic and prognostic of
bladder cancer and lung cancer [7, 9]. Furthermore,
over-expression of UHRF1 is shown to contribute to
worse survival of laryngeal squamous cell carcinoma
(LSCC) and serve as an independent prognostic factor
of LSCC [10]. Therefore, the present study aims at
exploring the effects of silent UHRF1 on proliferation
and apoptosis of human CSCC Caski cells and to
further study the related mechanism of cell apoptosis.
Methods
Tissue collection and cell culture
A total of 47 cases of CSCC tissues and 40 cases of
normal cervical tissues resected from benign tumors
were collected from Harbin Medical University Cancer
Hospital from June 2013 to December 2015. The nor-
mal tissues were classified as the Control group and
the CSCC tissues were as the CSCC group. The CSCC
cell lines CaSki were obtained from cell bank of
Chinese Academy of Sciences. The cells were cultured
in 90 % RPMI1640 (Gibco BRL Co. Led., New York,
USA) and 10 % Fetal bovine serum (FBS) (Gibco BRL
Life Technologies Inc., Grand Island, New York, USA).
UHRF1 siRNA and control siRNA were purchased
from Santa Cruz (sc-76805, Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA). When the cells merged to
50 %, lentivirus diluted by medium solution were
added for transfection. After 24 h, the virus was aspi-
rated and normal solution was replaced. The cells were
classified into 3 groups: the Blank group (CaSki cells
untransfected), the negative control (NC) group (CaSki
cells transfected with control siRNA) and the UHRF1
Silence group (CaSki cells transfected with UHRF1 siRNA).Quantificational real-time polymerase chain reaction
(qRT-PCR)
qRT-PCR was used for the detection of UHRF1 expres-
sion level in 47 cases of CSCC tissues, 40 normal cer-
vical tissues and differenttransfected CaSki cells (Blank
group, NC group, and UHRF1 Silence group). The
tissues were washed 3 times with phosphate buffered sa-
line (PBS). After 72-h culture, the cells were washed
again with PBS for 3 times. The total RNA extraction
was according to RNAiso Plus reagent kit (Takara Bio
Inc., Dalian, China) and reverse transcription was oper-
ated in conformity with PrimeScript RT reagent kit
(Takara Bio Inc., Dalian, China). The SteponePlus PCR
(Applied Biosystem, Foster City, CA, USA) system ap-
plied for fluorescence quantitative test was following:
cDNA solution 1.6 ul, 2X SYBR GREEN Taq PCR MIX
(Takara Bio Inc., Dalian, China) 5 ul, PCR upstream and
downstream primers (10 uM, each 0.2 ul) and deuterium
depleted water (DDW) 3 ul. Reaction condition was ini-
tial denaturation at 95 °C for 5 min, 95 °C 10 s, 58 °C
10 s, and 72 °C for 10 s, 60 cycles and extension at 72 °C
for 10 min. The detection gene was UHRF1 (Gene ID
29128) and internal reference gene was β-actin (Gene ID
11461). The primers (Invitrogen Biotechnology Co.
Shanghai, China) were listed in Table 1. The experiment
was repeated 3 times, and the average values were obtained.
Western blot assay
After transfection of 3 days, the cells were washed,
added with Radio immunoprecipitation assay (RIPA)
lysis buffer and protease inhibitor (Sigma, St. Louis,
USA) for homogenate, and centrifuged at 12,000 × g at
4 °C for 10 min. After bicinchoninic acid (BCA) (Boi-rad
Laboratories, Inc, Hercules, California, USA) detection
of the protein concentration, the supernatant was re-
served at −80 °C. Western blot applied 10 % sodium
dodecyl sulfate polyacrylamide gel electropheresis
(SDS-PAGE) gel. Each well was added with 20 ug
protein samples. The primary anti-bodies were Rabbit
anti-human-UHRF1, Caspase3, Caspase8, Caspase9,
Bax and Bcl-2 (Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA) and the cells were kept overnight at
4 °C. The secondary anti-body was POD-conjugated
goat anti-rabbit (1:5000) and the cells were main-
tained at room temperature for 30 min, which was
added with horseradish peroxidase (HRP) (Boi-rad
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Quant 350 and Image Quant TL-1 (GE Healthcare,
Fairfield, CT, USA) were applied to analyze the results.
The reference gene was β-actin. The experiment was
repeated 3 times, and the average values were obtained.
CCK-8 for cell proliferation
The CaSki cells were cultured in 96-hole plate at density
of 1 × 105 cells. Each group was designed with 4 dupli-
cated wells. After 24-h culture, the cell proliferation was
examined with Cell Counting Kit-8 (Thermo, USA) at
24, 48, 72 and 96 h. The procedures were as follows: After
the aspiration of the original medium, the cells were
added with CCK-8 solution. The medium was detected at
450 nm absorbance after 2-h culture. The experiment was
repeated 3 times, and the average values were obtained.
Flow cytometer
Propidium iodide (PI) was applied to analyze cell cycle,
and Annexin V-FITC and PI (Abcam Co., Cambridge,
MA, USA) were used for analysis of cell apoptosis rate.
The CaSki cells were washed twice with PBS and added
with 0.25 % pancreatin for digestion. After adjusting the
density to 105/ml, the cells were incubated with fluor-
escent antibody at room temperature for 30 min. The cells
were precipitated and suspended after 200 × g centrifu-
ging. Finally, the flow cytometer (BD Bioscience, San Jose,
CA, USA) was applied for analysis. The experiment was
repeated 3 times, and the average values were obtained.
Establishment of tumor-bearing nude mice model
A total of 24 female nude mice of 4–6 weeks were
(purchased from Shanghai Biomodel Organism Science &
Technology Development Co., Ltd.) fed under sun protec-
tion factor (SPF) environment. The nude mice were
injected with the CaSki cells in aseptic condition, and then
were assigned into 3 groups (each group with 8 mice): the
Blank group (injected with untransfected CaSki cell), the
NC group (injected with CaSki cells transfecting control
siRNA) and the UHRF1 Silence group (injected with
CaSki cells transfecting UHRF1 siRNA). The cell number
injected was 1 × 106 and the volume was 100 ul. Ten days
later, the maximum and minimum diameter of the tumor
was measured with vernier caliper every 5 days. The
tumor size =maximum diameter ×minimum diameter2.
Thirty days later, the tumor tissue on the back of nude
mice were taken out and measured the weight. The tissues
were fixed with 10 % formaldehyde. After dehydration, the
tissues were embedded with paraffin for staining analysis.
Immunohistochemical staining
The tissues were washed with PBS for 3 times and
fixed with 4 % paraformaldehyde. After embedding
with paraffin and slicing, the tissues were performedimmunohistochemical analysis. Firstly, the paraffin
sections were dewaxed and rehydrated and treated
with 3 % hydrogen peroxide for 15 min to block en-
dogenous peroxidase activity. Then the tissues were
heated with vapor for 30 min to restore antigen. The
tissues were later blocked in PBS chamber containing
1 % bovine serum albumin (BSA). The primary anti-
body was added for incubation at room temperature
for 30 min and then maintained overnight at 4 °C.
The primary antibody was rabbit polyclonal anti-
proliferating cell nuclear antigen (PCNA) and UHRF1
(Abcam Co., Cambridge, MA, USA) and the slicess were
kept overnight at 4 °C. The secondary antibody was POD-
conjugated goat anti-rabbit (1 : 5000) and the slices were
maintained at room temperature for 30 min, which was
added with horseradish peroxidase (HRP) (Boi-rad
Laboratories, Inc, Hercules, California, USA). The stained
slices were pictured at 400 × amplification.
Statistical methods
Data analysis was based upon the statistical package
for the social sciences (SPSS) version 20.0 (SPSS Inc.;
Chicago, IL, USA). Continuous data were displayed as
mean ± standard deviation, and differences between
two groups were examined by t test. And the differences
among multiple groups were analyzed with repeated
measurement of analysis of variance (ANOVA). Signifi-
cance was illustrated by P < 0.05.
Results
UHRF1 expression by qRT-PCR
The fluorescent quantitative PCR indicated that the
mRNA level of UHRF1 was elevated in the tissues of the
CSCC group in comparison with that in the Control
group (P < 0.05). And the UHRF1 mRNA expression in
the UHRF1 Silence group was lower than those in the
Blank group and the NC group (P < 0.05). No significant
difference was found regarding UHRF1 mRNA level be-
tween the Blank group and the NC group (P > 0.05,
Fig. 1). The findings confirmed that UHRF1 transcrip-
tion level was promoted in the CSCC tissues when com-
pared with the normal tissues and it could be inhibited
by UHRF1 siRNA in the CaSkin cell lines.
UHRF1 expression by Western blot assay
The results of Western blot revealed that UHRF1
protein expression in the CSCC group was higher
than that in the Control group (P < 0.05). And the
UHRF1 protein level in the UHRF1 Silence group was
reduced when compared with the Blank group and
the NC group (P < 0.05). No significant difference was
found regarding UHRF1 protein level between the
Blank group and the NC group (P > 0.05, Fig. 2). It





























































Fig. 1 UHRF1 mRNA expression detected by quantificational real-time polymerase chain reaction. a Comparison in UHRF1 expression between
CSCC tissues (n = 47) and normal cervical tissues (n = 40), revealing that UHRF1 expression in CSCC tissues was much higher than that in normal
cervical tissues; *, P < 0.05 compared with the Control group; b Comparison in UHRF1 expression among CaSki cells of different transfection
groups (n = 3), revealing that the UHRF1 Silence group had a significantly lower level of UHRF1 mRNA expression than the Blank group and
the NC group; #, P < 0.05 compared with the Blank group; &, P < 0.05 compared with the NC group; UHRF1, ubiquitin-like, containing plant































































Fig. 2 UHRF1 protein expression detected by Western blot. a Western blot map of CSCC tissues (n = 47), normal cervical tissues (n = 40) and
CaSki cells in different transfection groups (n = 3); b Comparison of UHRF1 protein expression between CSCC tissues (n = 47) and normal cervical
tissues (n = 40), showing that CSCC tissues had a significantly higher UHRF1 protein expression level than normal cervical tissues; *, P < 0.05 compared
with the Control group; c Comparison of UHRF1 protein expression among CaSki cells in different transfection groups (n = 3), showing that the UHRF1
Silence group had a significantly lower level of UHRF1 protein expression than the Blank group and the NC group; #, P < 0.05 compared with the Blank
group; &, P < 0.05 compared with the NC group; UHRF1, ubiquitin-like, containing plant homeodomain (PHD) and really interesting new gene (RING)
finger domains 1; CSCC, cervical squamous cell carcinoma; NC, negative control
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tissues and it could be inhibited by UHRF1 siRNA in
the CaSkin cell lines.
Cell proliferation by CCK-8
It was found that the cell proliferation ability in the
UHRF1 Silence group was reduced when compared with
the Blank group and the NC group (both P < 0.05). And
there was no significant difference between the Blank
group and the NC group (P > 0.05, Fig. 3). It was sug-
gested that the proliferation ability of the CaSki cells was
suppressed by UHRF1 siRNA.
Cell cycle by flow cytometer
The cells at S-G2M stage in the UHRF1 Silence group
were dropped when compared with the Blank group and
the NC group (P < 0.05, Fig. 4), while the cells at G0/G1
stage were elevated (P < 0.05). The UHRF1 Silence group
induced the apoptosis of CaSki cells, which could be
substantiated by the appearance of sub-G1 peak in the
flow cytometric DNA histogram. The peak appeared
ahead of the G0/G1 peak, and represented cell apoptosis.
No significant difference existed between the Blank
group and NC group (P > 0.05). Therefore, inhibiting
U HRF1 was able to repress cell proliferation to stagnate
the CSCC cells at G0/G1 stage.
Cell apoptosis by flow cytometer
It was found that the proportion of Annexin V positive
cells (early apoptosis cells and late apoptosis cells) in the
UHRF1 Silence group was increased in comparison with
the Blank group and the NC group (P < 0.05, Fig. 5). No
significant difference was found between the Blank
group and the NC group (P > 0.05). Thus, the cell apop-



















Fig. 3 Cell proliferation detected by CCK-8. At each time point, the
UHRF1 Silence group had a much lower proliferation ability than the
Blank group and the NC group; *, P < 0.05 compared with the Control
group, n = 3; UHRF1, ubiquitin-like, containing plant homeodomain
(PHD) and really interesting new gene (RING) finger domains 1;
NC, negative controlApoptosis protein expressions by Western blot
The expressions of the apoptosis proteins Caspase3,
Caspase8, Caspase9 and Bax and anti-apoptosis protein
Bcl-2 in the Blank group were not significantly different
from those in the NC group (all P > 0.05). However, the
expressions of above-mentioned apoptosis proteins in
the UHRF1 Silence were elevated, while the anti-
apoptosis protein was reduced (all P < 0.05, Fig. 6),
which further confirmed that the inhibition of UHRF1
promoted cell apoptosis of the CaSki cells.
Cell malignant transformation in tumor-bearing nude
mice model
The experiment indicated that the tumor growth speed
in the UHRF1 Silence group was slower than that in the
Blank group and NC group (P < 0.05, Fig. 7a). The tumor
in the UHRF1 Silence group was also thinner than that
in the Blank group and the NC group (P < 0.05, Fig. 7b).
The slice staining results suggested that the UHRF1 and
PCNA positive cells in the UHRF1 Silence group were
less than the Blank group and the NC group (Fig. 7c),
which further indicated that in the tumor-bearing nude
mice model, the cell proliferation in the UHRF1 Silence
group were significantly lower than the Blank group and
the NC group. Therefore, the silent UHRF1 could inhibit
the cell malignant transformation in the CaSki cells of
the nude mice.
Discussion
As a leading cause of mortality in women, cervical
cancer still exhibits unclear molecular mechanisms
[4]. Despite of the significant advances including
surgical techniques, radiotherapy and chemotherapy,
there are still nearly 30 % of patients diagnosed with
invasive cervical carcinoma that passes away due to
residual or recurrent disease [11]. However, increasing
evidence indicates that the expression or overexpres-
sion of UHRF1 is associated with a poor prognosis in
a variety of cancer types [7, 9]. Therefore, the aim of
the current study was to evaluate the potential associ-
ation between UHRF1 and CSCC. Consequently,
UHRF1 is over-expressed in CSCC and silencing
UHRF1 inhibits proliferation and promotes apopyosis
of the CSCC CaSKi cells.
In this study, we firstly assessed the expression level of
UHRF1 in the CSCC tissues. We found that UHRF1
mRNA and protein were highly regulated in CSCC
tissues in comparison to the normal cervical tissue, sug-
gesting that UHRF1 participates in the development and
evolvement of CSCC. Similarly, Yan et al. supported that
UHRF1 has been considered to be an oncogene which is
involved in tumorigenesis in ovarian cancer [6]. To our
knowledge, UHRF1 can form a complex with DNA






































































Fig. 4 Cell cycle detected by flow cytometer. Compared with the Blank group and the NC group, the ratio of S-G2M phase cells in UHRF1 Silence
group decreased significantly, while the ratio of G0/G1 phase cells increased obviously. The UHRF1 Silence group induced the apoptosis of CaSki
cells, which could be substantiated by the appearance of sub-G1 peak in flow cytometric DNA histogram. The peak appeared ahead of the G0/
G1 peak, and represented cell apoptosis. *, P < 0.05 compared with the Blank group; #, P < 0.05 compared with the NC group; n = 3; UHRF1,
ubiquitin-like, containing plant homeodomain (PHD) and really interesting new gene (RING) finger domains 1; NC, negative control
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of some tumor suppressor genes through its SRA do-
main, such as p16 INK4A, hMLH1, BRCA1 and RB1 [8].
According to former studies, high expression of UHRF1
was also detected in lung cancer cells, particularly in
prostate cancer and breast cancer and it seem that the
intensity of its over-expression was linked to the clinical
stage of the cancer [12, 13]. UHRF1 has recently been
shown to play an important role in DNA methylation
maintenance [14]. It has the ability to trigger the collec-
tion of DNMT and histone deacetylace-1 by binding
hemimethylated DNA via its SET- and RING-associated
domain [15–17]. Krifa et al. and Alhosin et al. have
proved that UHRF1, as an oncogene protein, has the po-
tential to suppress tumor suppressor gene expression
such as p16INK4A, hMLH1, BRCA1 along with RB1
through binding to methylated DNA and recruiting the
DNMT1 [8, 18]. Also, several studies indicate that over-
expression of UHRF1 plays a part in the changed DNA
methylation patterns and the establishment of aberrant
histone code [19, 20].Importantly, UHRF1 is essential for cell proliferation,
and depleting UHRF1 may inhibit cell proliferation and
lead to cell death. The results indicated that silencing
UHRF1 leads to a decrease in the proliferation of CaSki
cells and the apoptosis of CaSKi increases (the activity of
Caspase3, Caspase8, Caspase9, Bax apoptosis-related
protein increase). This is consistent with previous stud-
ies showing that down-regulation of UHRF1 leads to cell
growth inhibition [19, 20]. According to the research of
Li et al., up-regulated UHRF1 might increase cyclin D1
activityand Bax downregulation, resulting in G1 shortage
and inhibition of apoptosis and subsequent promotion
of cell proliferation respectively [5]. As it was reported,
the UHRF1 gene, its expression is associated with
increased cell proliferation, is a target for the transcrip-
tional activator E2F1 [21]. The results of nude mouse
experiment indicated that tumor grow more slowly in
UHRF1 silence group, implying that silencing UHRF1 can
suppress the tumorigenesis of CaSKi cells in nude mouse.
Moreover, UHRF1-knockout mouse embryonic stem cells



















































Blank NC UHRF1 silence
Fig. 5 Cell apoptosis detected by flow cytometer. Annexin V + PI - represents early apoptosis cells (Q4), annexin V + PI + represents late apoptosis
cells (Q2). The Annexin V-positive cells (early and late apoptosis cells) in the UHRF1 Silence group increased evidently as compared with the Blank
group and the NC group, which indicated increased apoptosis cells. *, P < 0.05 compared with the Blank group; #, P < 0.05 compared with the NC






















Fig. 6 Apoptosis related protein expression detected by Western blot. Compared with the Blank group and the NC group, apoptosis-related
proteins, namely Caspase3, Caspase8, Caspase9 and Bax, had a much higher level in the UHRF1 Silence group, while anti-apoptotic protein
(Bcl-2) had a much lower level. *, P < 0.05 compared with the Blank group; #, P < 0.05 compared with the NC group, n = 3; UHRF1, ubiquitin-like,
containing plant homeodomain (PHD) and really interesting new gene (RING) finger domains 1; NC, negative control
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Fig. 7 Tumor-bearing nude mice model experiment. a growth curve of tumor volume. The tumor growth speed in the UHRF1 Silence group was
much slower than that in the Blank group and NC group; b tumor weight. The tumor weight in the UHRF1 Silence group was much lower than
that in the Blank group and the NC group; c immunohistochemical staining of tumor sections; d the number of PCNA-positive cells. The number
of UHRF1-positive and PCNA-positive cells in the UHRF1 Silence group was much smaller than that in the Blank group and NC group. *, P < 0.05
compared with the NC group; #, P < 0.05 compared with the NC group; UHRF1, ubiquitin-like, containing plant homeodomain (PHD) and really
interesting new gene (RING) finger domains 1; NC, negative control; PCNA, proliferating cell nuclear antigen
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was prohibited when UHRF1 was down-regulating and
cells are stay at G0/G1 stage. Alteration in UHRF1 ex-
pression is correlated with the degree of the lung cancer
aggressiveness and it was detected in 50 % of the
patients in an early clinical stage [7]. Daskalos and his
colleagues reported that UHRF1 is a prominent epigen-
etic switch that controls cell cycle in lung carcinoma due
to its ability to smiantain the transcriptional silencing of
tumor suppressor genes through sustaining their pro-
moters in a hypermethylated condition [21]. UHRF1
mRNA and protein fluctuate with the cell cycle [22, 23],
inactivation or loss of UHRF1 blocks S-phase entry [24],
and zebrafish with a depletion-of-function mutation in
UHRF1 have reduced cell proliferation and promoted
cell apoptosis in hepatocyte [25]. These data suggests
that up-regulating cancer cells of UHRF1 may result in
cell death.
Conclusions
In conclusion, our study uncovered that UHRF1 overex-
pressed in CSCC and silent UHRF1 gene can reduce
tumorigenicity of the CaSki cells by decreasing its prolif-
eration capacity and making it stagnate at G0 and G1
phases as well as accelerating its apoptosis. Altogether,our data, combined with existing evidence provides a
basis for investigating UHRF1 as a possible therapeutic
target in human cancer.
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